News & Events - ArQule

Recent Events

ArQule to Report Third Quarter 2019 Financial Results on October 30, 2019
Burlington, MA
October 30, 2019

ArQule Announces Presentations on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Boston, MA
October 26-30, 2019

ArQule to Present Preclinical Data on Miransertib for the Treatment of Vascular Malformations at the 2019 American Society of Human Genetics (ASHG) Annual Meeting
Houston, TX
October 18, 2019

ArQule to Present at the 2019 Cantor Global Healthcare Conference on October 3, 2019
New York, NY
October 3, 2019

Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies
New York, NY
September 24, 2019

ArQule to Participate in Citi’s 14th Annual Biotech Conference on September 4, 2019
Boston, MA
September 4, 2019

ArQule to Participate in the BTIG Biotechnology Conference on Monday, August 12, 2019
New York, NY
August 12, 2019

ArQule to Present at the SVB Leerink Spotlight Series: Rare & Genetic Diseases on August 8, 2019
Boston, MA
August 8, 2019

ArQule to Report Second Quarter 2019 Financial Results on August 7, 2019
Burlington, MA
August 7, 2019

ArQule to Present at the 2019 RBC Capital Markets Global Healthcare Conference on May 21, 2019
New York, NY
May 21, 2019

ArQule to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 15, 2019
Las Vegas, NV
May 15, 2019

ArQule to Report First Quarter 2019 Financial Results on May 1, 2019
Burlington, MA
May 1, 2019

ArQule to Present at 18th Annual Needham Healthcare Conference on April 9, 2019
New York, NY
April 9, 2019

ArQule to Present at Oppenheimer’s 29th Annual Healthcare Conference
New York, New York
March 20, 2019

ArQule to Participate in the 31st Annual ROTH Conference on March 17-19, 2019
Dana Point, CA
March 17-19, 2019

ArQule to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
Burlington, MA
March 7, 2019

ArQule to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019
New York, New York
February 28, 2019

ArQule to Host Analyst Call Highlighting Clinical Progress from Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies
San Diego, California
December 3, 2018

ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 2018 American Society of Hematology (ASH) Annual Meeting
San Diego, California
December 1-4, 2018

ArQule to Present at the 30th Annual Piper Jaffray Healthcare Conference
New York, New York
November 28, 2018

ArQule to Present Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium
Dublin, Ireland
November 13-16, 2018

ArQule Reports Third Quarter 2018 Financial Results on October 31, 2018
Burlington, MA
October 31, 2018

American Society of Human Genetics (ASHG) 2018 Annual Meeting
San Diego, CA
October 16-20, 2018

ArQule to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology on October 2, 2018
New York, New York
October 2, 2018

ArQule to Present at the Cantor Global Healthca
New York, New York
October 1, 2018

ArQule to Participate in Citi’s 13th Annual Biotech Conference on September 6, 2018
Boston, MA
September 6, 2018

ArQule to Present at the 20th Annual Rodman & Renshaw Global Investment Conference on September 5, 2018
New York, New York
September 5, 2018

ArQule to Participate in the Annual B. Riley FBR Healthcare Conference on September 4, 2018
New York, New York
September 4, 2018

ArQule to Report Second Quarter 2018 Financial Results on August 1, 2018
Burlington, MA
August 1, 2018

ArQule to Present at The JMP Securities Life Sciences Conference on June 21, 2018
New York, New York
June 21, 2018

ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 23rd Congress of the European Hematology Association (EHA)
Stockholm, Sweden
June 15, 2018

ArQule to Present at the Jefferies 2018 Healthcare Conference on June 7, 2018
New York, New York
June 7, 2018

ArQule Reports First Quarter 2018 Financial Results
Burlington, MA
May 7, 2018

ArQule to host investor conference call including transaction details, AACR highlights and an update on clinical strategy
Burlington, MA
April 18, 2018

ArQule to Present Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
Chicago, IL
April 14 - April 18, 2018

ArQule to Present at the 17th Annual Needham Healthcare Conference on March 27, 2018
New York, NY
March 27, 2018

ArQule to Present at the 30th Annual Roth Conference on March 12, 2018
Dana Point, CA
March 12, 2018

ArQule Reports Fourth Quarter and Full Year 2017 Financial Results
Burlington, MA
March 5, 2018

ArQule to Present at The Leerink Partners 7th Annual Global Healthcare Conference on February 15, 2018
New York, New York
February 15, 2018

ArQule Reports Third Quarter 2017 Financial Results
Burlington, MA
November 9, 2017

ArQule Announces $9.5 Million Private Placement of Preferred Stock
Burlington, MA
November 8, 2017

ArQule to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26, 2017
New York, New York
September 26, 2017

ArQule Reports Second Quarter 2017 Financial Results
Burlington, MA
August 4, 2017

European Hematology Association (EHA) 22nd Congress
Madrid, Spain
June 22-25, 2017

American Society of Clinical Oncology (ASCO) Annual Meeting
Chicago, IL
June 2-6, 2017

ArQule To Report First Quarter 2017 Financial Results On May 3, 2017
Burlington, MA
May 3, 2017

ArQule to Present at the 16th Annual Needham Healthcare Conference on April 4, 2017
New York, NY
April 4, 2017

ArQule To Report Fourth Quarter and Year End 2016 Financial Results On March 7, 2017
Burlington, MA
March 7, 2017

The Leerink Partners 6th Annual Global Healthcare Conference
New York, New York
February 15, 2017

American Society of Hematology (ASH) Annual Meeting
San Diego, CA
December 3 – 6, 2016

American Heart Association (AHA)
New Orleans, LA
November 12 – 15, 2016

American Association For the Study of Liver Disease (AASLD)
Boston, MA
November 11 – 15, 2016

ArQule Reports Third Quarter 2016 Financial Results
Burlington, MA
November 7, 2016

The Leerink Partners Rare Disease and Immuno-Oncology Roundtable
New York, NY
September 28, 2016

2016 Society of Hematologic Oncology Fourth Annual Meeting
Houston, TX
September 7 to September 10, 2016

Second Quarter 2016 Earnings Results Call
Burlington, MA
August 3, 2016

ArQule Presents Preclinical Data for ARQ 531, a Proprietary Reversible Inhibitor of Wild Type and Mutant BTK, at the 2016 Pan Pacific Lymphoma Conference
Koloa, Hawaii
July 18 to 22, 2016

Cantor Fitzgerald's 2nd Annual Healthcare Conference
New York, New York
July 12, 2016

ESMO 18th World Congress on Gastrointestinal Cancer
Barcelona, Spain
June 29 to July 2, 2016

American Association for Cancer Research (AACR)
New Orleans, Louisiana
April 16 - 20, 2016

Needham Healthcare Conference
New York, NY
April 12, 2016

Fourth Quarter 2015 Earnings Results Call
Burlington, MA
February 29, 2016

RBC Capital Markets 2016 Global Healthcare Conference
New York, NY
February 23, 2016

Leerink Partners 5th Annual Global Healthcare Conference
New York, NY
February 11, 2016

The Cholangiocarcinoma Foundation 2016 Annual Conference
Salt Lake City, Utah
February 3 - 5, 2016

American Society of Cancer – Gastrointestinal Cancers Symposium
San Francisco, CA
January 21 – 23, 2016


Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300